Glaucoma UK is a small charity but has a big impact!

Over the past 15 months, our Eye Health for All pilot project helped us take an important step towards improving eye health awareness in Black African and Caribbean communities across the UK. An independent evaluation found that the project successfully raised awareness of glaucoma, helped people take action to protect their sight, and built valuable relationships with community organisations and local people. 

A huge thank you to our 2026 London Marathon runners: Krish, Natalie, Craig, Surju, Ben, Amy, Francesco, Richard and Omera, who ran for Glaucoma UK and have collectively raised more than £25,000 so far for our charity.

Lead investigator: Paddy Gunn

We are delighted to announce the winners of our 2024 Glaucoma UK/Royal College of Ophthalmologists Research Award. As a result of the high quality of applications received, the judging panel have awarded two projects, worth nearly £200,000 in total.

We’re delighted to announce that we’re now an affiliate charity of Our Future Health, which aims to be the UK’s biggest health research programme.  

Professor Ted Garway-Heath, Glaucoma UK Professor, appeared on BBC Radio 4’s In Touch programme to discuss his recent study which identified a new biomarker for glaucoma progression.

Acute angle closure is when your eye’s drainage system suddenly closes. It can be painful, and it can lead to a rapid rise in eye pressure. It can damage parts of your eye, including the cornea, lens, retina and optic nerve. This damage can lead to glaucoma (called angle closure glaucoma) and sight loss. If you think you might have acute angle closure, you should seek medical advice straight away. 

A recent study suggests that some common attention deficit hyperactivity disorder (ADHD) medications might increase the risk of glaucoma. This finding is important for the millions of people who use medications like atomoxetine, methylphenidate, and amphetamines.

We’re sharing this article from OcuPlan to inform you about the various care options available for your glaucoma care. Glaucoma UK does not endorse any particular service, acknowledging that everyone’s needs and situations are unique.

In honour of our golden jubilee, we are thrilled to launch the Pitts Crick Career Development Fellowship. This is a new three-year post-doctoral research fellowship, for a rising star in glaucoma research. In keeping with the original hopes and aspirations of our founder, Ronald Pitts Crick, we are looking to support a dedicated and ambitious individual who can play a pivotal role in transforming glaucoma diagnosis or treatment into the future.